Aardvark Therapeutics AARD
NASDAQ AARD
$5.35 +0.08 (+1.52%)
At close: Sep 29, 2026 · 4:00 PM EDT

Aardvark Therapeutics (AARD) Receivables (2024 - 2025)

Updated

Aardvark Therapeutics' Receivables came in at $1.4 million for Q3 2025, unchanged from the prior quarter.

Analysis

Aardvark Therapeutics (AARD) Receivables (2024 - 2025) Analysis & Trends

Going back to Q4 2024, Aardvark Therapeutics' Receivables data covers 4 quarters.

  • Business Quant data shows AARD's Receivables at $1.4 million (Q2 2025), $1.4 million (Q1 2025) and $1.4 million (Q4 2024) in the three quarters before Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 19.05 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 13.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.68 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 5.06 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.13 Bn
10 Aardvark Therapeutics 115.33 Mn 41.43 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 1.40 Mn
Jun 30, 2025 1.40 Mn
Mar 31, 2025 1.40 Mn
Dec 31, 2024 1.40 Mn
API Access

Aardvark Therapeutics Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=AARD&period=max&api_key=YOUR_API_KEY